search
Back to results

Clinical Trial on the Articular Pain With a Cucumber Supplement in Patients Diagnosed With Arthrosis (CUCART)

Primary Purpose

Osteoarthritis

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
nutraceutical
Sponsored by
Universidad Católica San Antonio de Murcia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis

Eligibility Criteria

40 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age over 40 years.
  • Subjects diagnosed with osteoarthritis with functional grades I-III according to the modified criteria of the American College of Rheumatology.
  • Subjects must have persistent knee pain associated with osteoarthritis with a baseline score of at least 30 mm on the VAS pain assessment.
  • Subjects should not present narcotic drugs or steroidal anti-inflammatory drugs or immunosuppressants in their treatment.

Exclusion Criteria:

  • Serious or terminal illnesses.
  • Subjects currently taking glucosamine, chondroitin sulfate, collagen or hyaluronic infiltrations or any supplement indicated for joint health.
  • Subjects with chronic inflammatory diseases that affect the musculoskeletal system (rheumatoid arthritis, gout, pseudo-gout, Paget's disease, chronic pain syndrome, etc.).
  • Subjects with a body mass index above 32.
  • Pregnant or lactating women.
  • Inability to understand informed consent.

Sites / Locations

  • Catholic University of Murcia

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Experimental group (cucumber)

control group Placebo (sucrose)

Arm Description

Consumption for 90 days of cucumber extract (20mg/day) Two capsules a day orally for 90 days.

Two capsules a day orally for 90 days.

Outcomes

Primary Outcome Measures

Change in Pain from baseline at 8 weeks
Visual analog scale from 0 to 10. The higher the value, the more pain.

Secondary Outcome Measures

Change in concomitant analgesic medication
The change in the need for the use of analgesic medications will be evaluated.
Quality of life test: WOMAC test
The quality of life of the subjects will be measured with the WOMAC test. It is a 24-item test that will measure the degree of pain: nothing, little, enough, a lot, and a lot, when performing activities in daily life.
Functional test
The balance and mobility of the subjects will be measured with the Timed Up and Go Test
Muscle function
Isokinetic dynamometry.
Inflammatory state IL-b
It is a blood test that measures cartilage degradation
Cartilage metabolism
It is a blood test that measures cartilage degradation
Liver safety variables
It is a blood test that measures the presence of some enzymes, proteins and bilirubin in the blood, with the aim of determining if there is any alteration in the liver. Enzyme GPT, GOT, Gamma GT, LDH, alkaline phosphatase and bilirubin (UI/L)

Full Information

First Posted
October 15, 2020
Last Updated
September 16, 2021
Sponsor
Universidad Católica San Antonio de Murcia
search

1. Study Identification

Unique Protocol Identification Number
NCT04607759
Brief Title
Clinical Trial on the Articular Pain With a Cucumber Supplement in Patients Diagnosed With Arthrosis
Acronym
CUCART
Official Title
Randomized Clinical Trial to Analyze the Efficacy of a Supplement Removed From Cucumber on the Articular Pain of Diagnosed Patients of Arthrosis
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
January 11, 2021 (Actual)
Primary Completion Date
July 31, 2021 (Actual)
Study Completion Date
September 1, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad Católica San Antonio de Murcia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Randomized, controlled, double-blind clinical trial of two parallel branches to analyze the efficacy of a supplement extracted from the cucumber on the joint pain of patients diagnosed with osteoarthritis.
Detailed Description
The subjects that meet the selection criteria will make a total of two visits to the research laboratory and will carry out the pre-established tests in the protocol. Subsequently, a statistical analysis will be carried out with the variables measured in the study to obtain results.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Experimental group (cucumber)
Arm Type
Experimental
Arm Description
Consumption for 90 days of cucumber extract (20mg/day) Two capsules a day orally for 90 days.
Arm Title
control group Placebo (sucrose)
Arm Type
Placebo Comparator
Arm Description
Two capsules a day orally for 90 days.
Intervention Type
Dietary Supplement
Intervention Name(s)
nutraceutical
Intervention Description
Subjects will consume two capsules for eight weeks
Primary Outcome Measure Information:
Title
Change in Pain from baseline at 8 weeks
Description
Visual analog scale from 0 to 10. The higher the value, the more pain.
Time Frame
The pain will be measured by a scale twice, at the beginning and at the end of the study (after an 8 week consumption).
Secondary Outcome Measure Information:
Title
Change in concomitant analgesic medication
Description
The change in the need for the use of analgesic medications will be evaluated.
Time Frame
Twice, once at the beginning of the trial in basal conditions and once at the end after 8 weeks of consumption.
Title
Quality of life test: WOMAC test
Description
The quality of life of the subjects will be measured with the WOMAC test. It is a 24-item test that will measure the degree of pain: nothing, little, enough, a lot, and a lot, when performing activities in daily life.
Time Frame
it will be measured twice, once at baseline or at the end of the study after 8 weeks of use
Title
Functional test
Description
The balance and mobility of the subjects will be measured with the Timed Up and Go Test
Time Frame
Twice, once at the beginning of the trial in basal conditions and once at the end after 8 weeks of consumption.
Title
Muscle function
Description
Isokinetic dynamometry.
Time Frame
Twice, once at the beginning of the trial in basal conditions and once at the end after 8 weeks of consumption.
Title
Inflammatory state IL-b
Description
It is a blood test that measures cartilage degradation
Time Frame
Twice, once at the beginning of the trial in basal conditions and once at the end after 8 weeks of consumption.
Title
Cartilage metabolism
Description
It is a blood test that measures cartilage degradation
Time Frame
Twice, once at the beginning of the trial in basal conditions and once at the end after 8 weeks of consumption.
Title
Liver safety variables
Description
It is a blood test that measures the presence of some enzymes, proteins and bilirubin in the blood, with the aim of determining if there is any alteration in the liver. Enzyme GPT, GOT, Gamma GT, LDH, alkaline phosphatase and bilirubin (UI/L)
Time Frame
Twice, once at the beginning of the trial in basal conditions and once at the end after 8 weeks of consumption.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age over 40 years. Subjects diagnosed with osteoarthritis with functional grades I-III according to the modified criteria of the American College of Rheumatology. Subjects must have persistent knee pain associated with osteoarthritis with a baseline score of at least 30 mm on the VAS pain assessment. Subjects should not present narcotic drugs or steroidal anti-inflammatory drugs or immunosuppressants in their treatment. Exclusion Criteria: Serious or terminal illnesses. Subjects currently taking glucosamine, chondroitin sulfate, collagen or hyaluronic infiltrations or any supplement indicated for joint health. Subjects with chronic inflammatory diseases that affect the musculoskeletal system (rheumatoid arthritis, gout, pseudo-gout, Paget's disease, chronic pain syndrome, etc.). Subjects with a body mass index above 32. Pregnant or lactating women. Inability to understand informed consent.
Facility Information:
Facility Name
Catholic University of Murcia
City
Murcia
ZIP/Postal Code
30107
Country
Spain

12. IPD Sharing Statement

Learn more about this trial

Clinical Trial on the Articular Pain With a Cucumber Supplement in Patients Diagnosed With Arthrosis

We'll reach out to this number within 24 hrs